Hypothyroidism enhances tumor invasiveness and metastasis development

PLoS ONE

Volumn 4, Issue 7, 2009, Pages

  Martínez Iglesias, Olaia ^a   García Silva, Susana ^a   Regadera, Javier ^b   Aranda, Ana ^a  

^a CSIC   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN E; THYROID HORMONE RECEPTOR BETA; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INVASION; CONTROLLED STUDY; DISEASE ASSOCIATION; EUTHYROIDISM; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOTHYROIDISM; LIVER CARCINOMA; LUNG METASTASIS; MESENCHYMAL PHENOTYPE; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; TUMOR GROWTH; XENOGRAFT; ANIMAL; IMMUNOHISTOCHEMISTRY; MESODERM; METASTASIS; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

MUS MUSCULUS;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; HUMANS; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; MESODERM; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION;

EID: 68149137223     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006428     Document Type: Article

References (49)

1. Aranda A, Pascual A (2001) Nuclear hormone receptors and gene expression. Physiol Rev 81: 1269-1304.
2. Flamant F, Baxter JD, Forrest D, Refetoff S, Samuels H, et al. (2006) International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptors. Pharmacol Rev 58: 705-711.
3. Bronnegard M, Torring O, Boos J, Sylven C, Marcus C, et al. (1994) Expression of thyrotropin receptor and thyroid hormone receptor messenger ribonucleic acid in normal, hyperplastic, and neoplastic human thyroid tissue. J Clin Endocrinol Metab 79: 384-389.
4. Drabkin H, Kao FT, Hartz J, Hart I, Gazdar A, et al. (1988) Localization of human ERBA2 to the 3p22-3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer. Proc Natl Acad Sci U S A 85: 9258-9262.
5. Gonzalez-Sancho JM, Garcia V, Bonilla F, Munoz A (2003) Thyroid hormone receptors/THR genes in human cancer. Cancer Lett 192: 121-132.
6. Horkko TT, Tuppurainen K, George SM, Jernvall P, Karttunen TJ, et al. (2006) Thyroid hormone receptor beta1 in normal colon and colorectal cancer-association with differentiation, polypoid growth type and K-ras mutations. Int J Cancer 118: 1653-1659.
7. Kamiya Y, Puzianowska-Kuznicka M, McPhie P, Nauman J, Cheng SY, et al. (2002) Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma. Carcinogenesis 23: 25-33.
8. Lee JW, Chen CL, Juang BT, Chen JY, Yang CS, et al. (2000) Elevated expression of thyroid hormone receptor alpha 2 (c-erb A- alpha 2) in nasopharyngeal carcinoma. Br J Cancer 83: 1674-1680.
9. Markowitz S, Haut M, Stellato T, Gerbic C, Molkentin K (1989) Expression of the ErbA-beta class of thyroid hormone receptors is selectively lost in human colon carcinoma. J Clin Invest 84: 1683-1687.
10. Puzianowska-Kuznicka M, Krystyniak A, Madej A, Cheng SY, Nauman J (2002) Functionally impaired TR mutants are present in thyroid papillary cancer. J Clin Endocrinol Metab 87: 1120-1128.
11. Rocha AS, Marques R, Bento I, Soares R, Magalhães J, et al. (2007) Thyroid hormone receptor beta mutations in the 'hot-spot region' are rare events in thyroid carcinomas. J Endocrinol 192: 83-86.
12. Safer JD, Colan SD, Fraser LM, Wondisford FE (2001) A pituitary tumor in a patient with thyroid hormone resistance: a diagnostic dilemma. Thyroid 11: 281-291.
13. Wang CS, Lin KH, Hsu YC (2002) Alterations of thyroid hormone receptor alpha gene: frequency and association with Nm23 protein expression and metastasis in gastric cancer. Cancer Lett 175: 121-127.
14. Yokota J, Yamamoto T, Miyajima N, Toyoshima K, Nomura N, et al. (1988) Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Oncogene 2: 283-2877.
15. Chan IH, Privalsky ML (2006) Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs. Oncogene 25: 3576-3588.
16. Lin KH, Shieh HY, Chen SL, Hsu HC (1999) Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells. Mol Carcinog 26: 53-61.
17. Lin KH, Wu YH, Chen SL (2001) Impaired interaction of mutant thyroid hormone receptors associated with human hepatocellular carcinoma with transcriptional coregulators. Endocrinology 142: 653-662.
18. Lin KH, Zhu XG, Hsu HC, Chen SL, Shieh HY, et al. (1997) Dominant negative activity of mutant thyroid hormone alpha1 receptors from patients with hepatocellular carcinoma. Endocrinology 138: 5308-5315.
19. Li Z, Meng ZH, Chandrasekaran R, Kuo WL, Collins CC, et al. (2002) Biallelic inactivation of the thyroid hormone receptor beta1 gene in early stage breast cancer. Cancer Res 62: 1939-1943.
20. Silva JM, Dominguez G, Gonzalez-Sancho JM, García JM, Silva J, et al. (2002) Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer. Oncogene 21: 4307-4316.
21. Aranda A, Martínez-Iglesias O, Ruiz-Llorente L, García-Carpizo V, Zambrano A (2009) Thyroid receptor: roles in cancer. Trends Endocrinol Metab, In the Press.
22. Martinez-Iglesias O, Garcia-Silva S, Tenbaum SP, Regadera J, Larcher F, et al. (2009) Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis. Cancer Res 69: 501-509.
23. Suzuki H, Willingham MC, Cheng SY (2002) Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis. Thyroid 12: 963-969.
24. Furumoto H, Ying H, Chandramouli GV, Zhao L, Walker RL, et al. (2005) An unliganded thyroid hormone beta receptor activates the cyclin D1/ cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis. Mol Cell Biol 25: 124-135.
25. Beatson G (1896) On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases. Lancet 2: 104-107.
26. Alvarado-Pisani AR, Chacon RS, Betancourt LJ, Lopez-Herrera L (1986) Thyroid hormone receptors in human breast cancer: effect of thyroxine administration. Anticancer Res 6: 1347-1351.
27. Smyth PP (1997) The thyroid and breast cancer: a significant association? Ann Med 29: 189-191.
28. Yokoe T, Iino Y, Takei H, Horiguchi J, Koibuchi Y, et al. (1996) Relationship between thyroid-pituitary function and response to therapy in patients with recurrent breast cancer. Anticancer Res 16: 2069-2072.
29. Cristofanilli M, Yamamura Y, Kau SW, Bevers T, Strom S, et al. (2005) Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer 103: 1122-1128.
30. Hercbergs AA, Goyal LK, Suh JH, Lee S, Reddy CA, et al. (2003) Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study. Anticancer Res 23: 617-626.
31. Reddy A, Dash C, Leerapun A, Mettler TA, Stadheim LM, et al. (2007) Hypothyroidism: a possible risk factor for liver cancer in patients with no known underlying cause of liver disease. Clin Gastroenterol Hepatol 5: 118-123.
32. Ledda-Columbano GM, Perra A, Concas D, Cossu C, Molotzu F, et al. (2003) Different effects of the liver mitogens triiodo-thyronine and ciprofibrate on the development of rat hepatocellular carcinoma. Toxicol Pathol 31: 113-120.
33. Ledda-Columbano GM, Perra A, Piga R, Pibiri M, Loi R, et al. (1999) Cell proliferation induced by 3,3′,5-triiodo-L-thyronine is associated with a reduction in the number of preneoplastic hepatic lesions. Carcinogenesis 20: 2299-2304.
34. Perra A, Kowalik MA, Pibiri M, Ledda-Columbano GM, Columbano A (2008) Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype. Hepatology 2009 49: 1287-1296.
35. Zavacki AM, Ying H, Christoffolete MA, Aerts G, So E, et al. (2005) Type 1 iodothyronine deiodinase is a sensitive marker of peripheral thyroid status in the mouse. Endocrinology 146: 1568-1575.
36. Junqueira LC, Bignolas G, Brentani RR (1979) Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11: 447-455.
37. Mueller MM, Fusenig NE (2004) Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4: 839-849.
38. Albini A, Sporn MB (2007) The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7: 139-147.
39. Yang J, Weinberg RA (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818-829.
40. Yilmaz M, Christofori G (2009) EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28: 15-33.
41. Dayan D, Hiss Y, Hirshberg A, Bubis JJ, Wolman M (1989) Are the polarization colors of picrosirius red-stained collagen determined only by the diameter of the fibers?. Histochemistry 93: 27-29.
42. Koren R, Yaniv E, Kristt D, Shvero J, Veltman V, et al. (2001) Capsular collagen staining of follicular thyroid neoplasms by picrosirius red: role in differential diagnosis. Acta Histochem 103: 151-157.
43. Gupta GP, Massague J (2006) Cancer metastasis: building a framework. Cell 127: 679-695.
44. Nguyen DX, Massague J (2007) Genetic determinants of cancer metastasis. Nat Rev Genet 8: 341-352.
45. Minn AJ, Gupta GP, Padua D, Bos P, Nguyen DX, et al. (2007) Lung metastasis genes couple breast tumor size and metastatic spread. Proc Natl Acad Sci U S A 104: 6740-6745.
46. Garcia-Silva S, Aranda A (2004) The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation. Mol Cell Biol 24: 7514-7523.
47. Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, et al. (2005) Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146: 2864-2871.
48. Davis FB, Tang HY, Shih A, Shih A, Keating T, et al. (2006) Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. Cancer Res 66: 7270-7275.
49. Escobar-Morreale HF, Escobar del Rey FE, Obregon MJ, Morreale de Escobar G (1996) Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat. Endocrinology 137: 2490-2502.